Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
MBOT
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
globenewswire.com
8 hours ago
zacks.com
14 hours ago
zacks.com
14 hours ago
Quote Panel
Key Metrics
Earnings Growth
YoY
Current
Estimates
Q3.23
N/A
-0.21
vs -0.49
Q4.23
N/A
-0.26
vs -0.54
Q1.24
N/A
-0.17
vs -0.38
Q2.24
N/A
-0.17
vs -0.25
Q3.24
N/A
-0.20
vs -0.21
Q4.24
N/A
-0.20
vs -0.26
Q1.25
N/A
-0.08
vs -0.17
Q2.25
N/A
-0.10
vs -0.17
Q3.25
N/A
-0.08
vs -0.20
Q4.25
N/A
-0.04
vs -0.20
Sales Growth
YoY
Current
Estimates
Q3.23
NA
NA vs NA
Q4.23
NA
142K vs NA
Q1.24
NA
NA vs NA
Q2.24
NA
NA vs NA
Q3.24
NA
NA vs NA
Q4.24
-41%
84K vs 142K
Q1.25
NA
NA vs NA
Q2.25
NA
NA vs NA
Q3.25
NA
630K vs NA
Q4.25
+5852%
5M vs 84K
Return on Equity
QoQ
Q1.23
-59%
-0.59
vs -0.41
Q2.23
-24%
-0.24
vs -0.59
Q3.23
-33%
-0.33
vs -0.24
Q4.23
-70%
-0.70
vs -0.33
Q1.24
-38%
-0.38
vs -0.70
Q2.24
-41%
-0.41
vs -0.38
Q3.24
-84%
-0.84
vs -0.41
Q4.24
-96%
-0.96
vs -0.84
Q1.25
-9%
-0.09
vs -0.96
Q2.25
-12%
-0.12
vs -0.09
Institutionnal Ownership
QoQ
Q1.23
26
26
vs 21
24%
Q2.23
27
27
vs 26
4%
Q3.23
30
30
vs 27
11%
Q4.23
37
37
vs 30
23%
Q1.24
32
32
vs 37
-14%
Q2.24
34
34
vs 32
6%
Q3.24
23
23
vs 34
-32%
Q4.24
35
35
vs 23
52%
Q1.25
46
46
vs 35
31%
Q2.25
52
52
vs 46
13%
Forecast
2026-Revenue
256%2026-EPS
2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available
Relative Strength
MBOT
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
NASDAQ
Unprofitable
Unprofitable
-0.63Â ( -15.56%)
Pre-market 3.54$0.12 (3.36%)
Relative Strenght
94
Volume Buzz
240%
Earning Acce
No
Dist 52w H.
27%